|
|
Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP Study
Nadège Néant
,
Minh Lê
,
Stéphane Bouchet
,
Jennifer Lagoutte-Renosi
,
Matthieu Grégoire
et al.
Article dans une revue
hal-05240572v1
|
|
|
Vancomycin population pharmacokinetic models: Uncovering pharmacodynamic divergence amid clinicobiological resemblance
Peggy Gandia
,
Sahira Chaiben
,
Nicolas Fabre
,
Didier Concordet
Article dans une revue
hal-04817060v1
|
|
|
Development of a ribavirin dosing regimen in transplant recipients with chronic hepatitis E virus infection: a population pharmacokinetic and -dynamic model
Midas B Mulder
,
Martijn van Noort
,
Robert A de Man
,
Nassim Kamar
,
Joep de Bruijne
et al.
Article dans une revue
hal-05523280v1
|
|
|
Multidimensional reference regions is a new tool to optimize the personalized care of patients
Peggy Gandia
,
Angélo Faget
,
Thibaut Jamme
,
Jérôme Ausseil
,
Didier Concordet
Article dans une revue
hal-05161766v1
|
|
|
JC Virus–Related Retinopathy
Fanny Varenne
,
Aurore Siegfried-Vergnon
,
Sébastien Lhomme
,
Emmanuel Treiner
,
Béatrice Pignolet
et al.
Article dans une revue
hal-05514391v1
|
|
|
A population pharmacokinetic model for sertraline in women during the perinatal period—A contribution from the ConcePTION project
Anaëlle Monfort
,
Evelina Cardoso
,
Chin B Eap
,
Nicolas Ansermot
,
Severine Crettol
et al.
Article dans une revue
hal-04662844v1
|
|
|
Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding: A human lactation study from the ConcePTION project
Hedvig Nordeng
,
Christine Wegler
,
Annika Lindqvist
,
Erik Melander
,
Mikaela Magnusson
et al.
Article dans une revue
hal-04948333v1
|
|
|
Hypoalbuminemia and Pharmacokinetics: When the Misunderstanding of a Fundamental Concept Leads to Repeated Errors over Decades
Peggy Gandia
,
Sarah Decheiver
,
Manon Picard
,
Romain Guilhaumou
,
Sarah Baklouti
et al.
Article dans une revue
hal-04061765v1
|
|
|
Exploration of the relationship between cumulative exposure to tobramycin and ototoxicity in patients with cystic fibrosis
Justine Madaule
,
Félix Valenzuela
,
Marie Mittaine
,
Yohan Gallois
,
Blandine Baladi
et al.
Article dans une revue
hal-04086358v1
|
|
|
“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring
Sarah Baklouti
,
Peggy Gandia
,
Didier Concordet
Article dans une revue
hal-03670618v1
|
|
|
Why Is It Desirable To Do the External Evaluation of a Population Pharmacokinetic Model?
Sarah Baklouti
,
S. Marolleau
,
P. Chavanet
,
E. Bonnet
,
Didier Concordet
et al.
Article dans une revue
hal-03578727v1
|
|
|
Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age : A Retrospective Monocentric Cohort Study
Stella Rousset
,
Margaux Lafaurie
,
Hélène Guet-Revillet
,
Caroline Protin
,
Jean Le Grusse
et al.
Article dans une revue
hal-03158686v1
|
|
|
Maraviroc exposure is influenced by exogenous thyrotoxicosis
David Metsu
,
Christian Aquilina
,
Pierre Delobel
,
Peggy Gandia
,
Frédérique Savagner
et al.
Article dans une revue
hal-03473015v1
|
|
|
Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure
Francoise Stanke-Labesque
,
Didier Concordet
,
Zoubir Djerada
,
Stephane Bouchet
,
Caroline Solas
et al.
Clinical Pharmacology and Therapeutics, 2021, Therapeutic Innovations in Infectious Diseases, 109 (4), pp.1030-1033. ⟨10.1002/cpt.2196⟩
Article dans une revue
hal-03191652v1
|
|
|
Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection
Midas B Mulder
,
Robert A Man
,
Nassim Kamar
,
Gűlcan Durmaz
,
Joep Bruijne
et al.
Article dans une revue
hal-03580025v1
|
|
|
Tacrolimus Intrapatient Variability After Switching From Immediate or Prolonged-Release to Extended-Release Formulation, After an Organ Transplantation
Arnaud del Bello
,
Clotilde Gaible
,
Nathalie Longlune
,
Anne-Laure Hebral
,
Lauren Esposito
et al.
Article dans une revue
hal-03623073v1
|
|
|
Efficacy of dihydroartemisinin/piperaquine in patients with noncomplicated Plasmodium falciparum malaria in Yaoundé, Cameroon
Mélissa Mairet-Khedim
,
Sandrine Nsango
,
Christelle Ngou
,
Sandie Menard
,
Camille Roesch
et al.
Article dans une revue
pasteur-03494748v1
|
|
|
Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02624662v1
|
|
|
Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
Didier Concordet
,
Peggy Gandia
,
J L Montastruc
,
Alain Bousquet‐mélou
,
P Lees
et al.
Article dans une revue
hal-02627432v1
|
|
|
Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations
Eloise Baudou
,
Anne Lespine
,
Geneviève Durrieu
,
François André
,
Peggy Gandia
et al.
Article dans une revue
hal-02928174v1
|
|
|
Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study
Camille Mané
,
Clément Delmas
,
Jean Porterie
,
Géraldine Jourdan
,
Patrick Verwaerde
et al.
Article dans une revue
hal-02940915v1
|
|
|
Authors' Reply to Yu et al.: ""Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02619187v1
|
|
|
Authors' Reply to Nicolas: "Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02627433v1
|
|
|
Comparing ultrafiltration and equilibrium dialysis to measure unbound plasma dolutegravir concentrations based on a design of experiment approach
David Metsu
,
Thomas Lanot
,
François Fraissinet
,
Didier Concordet
,
Véronique V. Gayrard-Troy
et al.
Article dans une revue
hal-02911804v1
|
|
|
Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics
Guillaume Martin-Blondel
,
Stéphanie Ruiz
,
Marlene Murris
,
Stanilas Faguer
,
Véronigue Duhalde
et al.
Article dans une revue
hal-03167732v1
|
|
|
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients
Sarah Baklouti
,
Clémence Massip
,
Camille Mane
,
Hélène Guet-Revillet
,
Marlene Murris
et al.
Article dans une revue
hal-02625024v1
|
|
|
Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)
Romain Guilhaumou
,
Sihem Benaboud
,
Youssef Bennis
,
Claire Dahyot-Fizelier
,
Eric Dailly
et al.
Article dans une revue
hal-02095159v1
|
|
|
Authors' Reply to Coste et al.:"Levothyrox New and Old Formulations: Are they Switchable for Millions of Patients?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02623560v1
|
|
|
Authors' Reply to Lechat et al.: " New and Old Formulations: Are they Switchable for Millions of Patients?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02619071v1
|
|
|
Suicide Attempts
Juliette Salles
,
Bernard Tiret
,
Adeline Gallini
,
Peggy Gandia
,
Christophe Arbus
et al.
Article dans une revue
hal-03464218v1
|
|
|
Authors'Reply to Castello-Bridoux et al.:"Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02627694v1
|
|
|
Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02095017v1
|
|
|
Author's Reply to Trechot: "Comment on Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02619069v1
|
|
|
HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy
Claire Guerveno
,
Stéphanie Raymond
,
David Metsu
,
Peggy Gandia
,
Jacques Izopet
et al.
Article dans une revue
hal-02618284v1
|
|
|
Pourquoi, comment et où dose-t-on les antihypertenseurs en 2019 ?
Beatrice Bouhanick
,
Pauline Fonquernie
,
India Bedue
,
Anaïs Schavgoulidze
,
Peggy Gandia
Article dans une revue
hal-02624869v1
|
|
|
Refining the therapeutic range of posaconazole and isavuconazole for efficient therapeutic drug monitoring using a bioassay approach
Théo Willeman
,
Julia Tonini
,
Cécile Garnaud
,
Sébastien Bailly
,
Peggy Gandia
et al.
Article dans une revue
hal-02976876v1
|
|
|
Authors' Reply to Nicolas:"New and Old Formulations: Are they Switchable for Millions of Patients?
Didier Concordet
,
Peggy Gandia
,
Jean-Louis Montastruc
,
Alain Bousquet‐mélou
,
Peter Lees
et al.
Article dans une revue
hal-02620199v1
|
|
|
Dosage des médicaments antihypertenseurs en France en 2019 et observance.
Beatrice Bouhanick
,
Bernard Vaïsse
,
Anaïs Schavgoulidze
,
Peggy Gandia
Article dans une revue
hal-02624854v1
|
|
|
Memory impairment following intentional self-poisoning with benzodiazepines
Juliette Salles
,
Jérémie Pariente
,
Laurent Schmitt
,
Dominique Lauque
,
Thomas Lanot
et al.
Article dans une revue
hal-03641012v1
|
|
|
Isavuconazole Kinetic Exploration for Clinical Practice.
Léa Darnaud
,
Fabien Lamoureux
,
Cendrine Godet
,
Sandrine Pontier
,
Alexia Debard
et al.
Article dans une revue
hal-02628582v1
|
|
|
Efavirenz and lopinavir levels in HIV-infected women and their nursing infants, in Mali
Aboubacar Alassane Oumar
,
Kadiatou Bagayoko-Maiga
,
Aliou Bahachimi
,
Mamoudou Maiga
,
Marie-Christine Cere
et al.
Article dans une revue
hal-02625041v1
|
|
|
Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods
David Metsu
,
Thomas Lanot
,
François Fraissinet
,
Mélanie Picot
,
Didier Concordet
et al.
Article dans une revue
hal-02621511v1
|
|
|
Population pharmacokinetics of tracers: A new tool for medical imaging?
Peggy Gandia
,
Cyril Jaudet
,
Etienne Chatelut
,
Didier Concordet
Article dans une revue
hal-01607048v1
|
|
|
Pharmacokinetics of teicoplanin in a breastfeeding mother
François Fraissinet
,
Marine Lesourd
,
Nicolas Naudoux
,
David Metsu
,
Peggy Gandia
Article dans une revue
hal-01600682v1
|
|
|
Population pharmacokinetic approach applied to positron emission tomography: Computed tomography for tumor tissue identification in patients with glioma
Peggy Gandia
,
Cyril Jaudet
,
Hendrik Everaert
,
Johannes Heemskerk
,
Anne Marie Vanbinst
et al.
Article dans une revue
hal-01601882v1
|
|
|
Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?
David Metsu
,
Patrick Séraissol
,
Pierre Delobel
,
Christel Cinq-Frais
,
Lise Cuzin
et al.
Article dans une revue
hal-01907438v1
|
|
|
Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?
David Metsu
,
Pierre-Louis Toutain
,
Etienne Chatelut
,
Pierre Delobel
,
Peggy Gandia
Article dans une revue
hal-01608734v1
|
|
|
Quinine unbound concentration is the best marker for therapeutic drug monitoring.
Carlos de Pablos-Martinez
,
Lydie Porte
,
François Fraissinet
,
Antoine Berry
,
Patrick Séraissol
et al.
Article dans une revue
hal-01601653v1
|
|
|
Quinine unbound concentration has to be used for therapeutic drug monitoring.
Carlos de Pablos-Martinez
,
Lydie Porte
,
François Fraissinet
,
Antoine Berry
,
Patrick Séraissol
et al.
Article dans une revue
hal-02634648v1
|
|
|
Problèmes et difficultés rencontrés lors de la planification et de l'analyse d'un essai de bioéquivalence.
Pierre-Louis Toutain
,
Peggy Gandia
,
Alain Bousquet‐mélou
La Lettre du Pharmacologue, 2014, 28 (2), pp.37-50
Article dans une revue
hal-02630493v1
|
|
|
Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships.
Aurélie Prémaud
,
Annick Rousseau
,
Gyasi Johnson
,
Cindy Canivet
,
Peggy Gandia
et al.
Article dans une revue
istex
inserm-00926481v1
|
|
|
Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.
Franck Saint-Marcoux
,
V. Guigonis
,
S. Decramer
,
P. Gandia
,
B. Ranchin
et al.
Article dans une revue
istex
inserm-00926458v1
|
|
|
Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation
Stéphane Firmin
,
Peggy Gandia
,
Diego Morgavi
,
Georges Houin
,
Jp Jouany
et al.
Article dans une revue
hal-00604043v1
|
|
|
Immediate and delayed hypersensitivity reactions to iodinated radiographic contrast agents: an update.
D. Khachman
,
Peggy Gandia
,
Francois Sallerin
,
Nicolas Mailly
Article dans une revue
istex
hal-02665979v1
|
|
|
Clomipramine in breast milk: a case study
D Khachman
,
Peggy Gandia
,
Ma Gaillard
,
P Seraissol
,
P Mendousse
et al.
Journal de Pharmacie Clinique, 2009, pp.33-38
Article dans une revue
hal-02654422v1
|
|
|
Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.
Cindy Canivet
,
Lionel Rostaing
,
Sylvain Galvani
,
Torsten Böhler
,
Peggy Gandia
et al.
Article dans une revue
istex
inserm-00410375v1
|
|
|
Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome
Cindy Canivet
,
Lionel Rostaing
,
Sylvain Galvani
,
Torsten Böhler
,
Peggy Gandia
et al.
Article dans une revue
istex
hal-02352459v1
|
|
|
Pharmacodynamic effects of cinacalcet after kidney transplantation: once- versus twice-daily dose.
Nassim Kamar
,
Isabelle Gennero
,
Luciana Spataru
,
Laure Esposito
,
Joelle Guitard
et al.
Article dans une revue
istex
inserm-00409076v1
|
|
|
Transfer of benzodiazepines into breast milk: clinical and analytical aspects
D Khachman
,
Peggy Gandia
,
F Sena
,
C Tortissier
,
P Seraissol
et al.
Annales de Toxicologie Analytique, 2008, pp.165-179
Article dans une revue
hal-02661242v1
|
|
|
Oral absorption of ampicillin: role of paracellular route vs. PepT1 transporter.
Guylène Lafforgue
,
Cécile Arellano
,
Christelle Vachoux
,
John Woodley
,
Claude Philibert
et al.
Article dans une revue
istex
hal-00517537v1
|